
|Podcasts|July 12, 2019
Tapping Into Great Progress Made in GI Cancers in Tampa
Author(s)Onclive Team
We traveled to Tampa, Florida, for a State of the Science Summit™ on Gastrointestinal Malignancies, which featured insights from the faculty from Moffitt Cancer Center and Mayo Clinic.
Advertisement
We recently traveled to Tampa, Florida, for a State of the Science Summit™ on Gastrointestinal Malignancies. At the meeting, faculty from Moffitt Cancer Center and Mayo Clinic reviewed the latest data in gastrointestinal oncology, covering all aspects of current care, from patient selection to the optimal timing of targeted therapy, immunotherapy, and chemotherapy, in neuroendocrine tumors, hepatocellular carcinoma, pancreatic cancer, gastric and gastroesophageal cancer, and colorectal cancer.
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
Targeted Therapies, ADCs, and Oral SERD Combos Expand Treatment Possibilities Across Breast Cancer Settings
2
Head and Neck Oncologists Highlight Practice-Informing Research From ASCO 2026
3
Dr Galsky on the Current Roles of Biomarkers in Bladder Cancer
4
Sonrotoclax Plus Zanubrutinib Yields High Undetectable MRD Rates in Treatment-Naive CLL/SLL
5






































































